Pura Vida Investments, LLC Aclaris Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

  • $145 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.74 - $17.92 $470,110 - $864,926
-48,266 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.49 $592,223 - $892,438
48,266 New
48,266 $702,000
Q2 2021

Aug 16, 2021
SELL
$17.08 - $29.6 $3 Million - $5.2 Million
-175,799 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$5.86 - $27.73 $737,182 - $3.49 Million
125,799 Added 251.6%
175,799 $4.43 Million
Q4 2020

Feb 16, 2021
BUY
$2.65 - $7.61 $132,500 - $380,500
50,000 New
50,000 $324,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email